A recent Cell paper by Saini et al. presents StealTHY, an immunogen-free CRISPR platform, enabling accurate gene discovery and revealing hidden carcinoma metastasis drivers like AMH-AMHR2 in immunocompetent models.
A recent Nature Medicine paper by the Aceto and Ligorio groups suggests that spikes in tumor cell clusters and macrovascular infiltration are key end-of-life events in cancer, providing a rationale for future trials to block large-vessel invasion.
Prof. Dr. Richard Grose, Professor of Cancer Cell Biology at Barts Cancer Institute, Queen Mary University of London, will give a seminar on August 29th, 2025, at 12pm, in the seminar room HPL J28. The seminar is entitled "Targeting Ephrin signalling to disrupt stromal-cancer crosstalk in pancreatic cancer". Guests are welcome!